A Phase 1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Assess Safety, Tolerability and Antitumor Activities of the Combination of BGB-3111 with BGB-A317 in Subjects with B-Cell Lymphoid Malignancies

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/16/PMCC/8.
SSA Reference Number: SSA/16/MonH/166.
Monash Health HREC Ref: 16228X
Effective start/end date30/04/1929/04/24


  • clinical trial
  • phase 1 study
  • lymphoma
  • treatment efficacy